BIGG Rec Logo
BIGG Rec Logo
New Evidence Available

Updated Recommendation

A new evidence synthesis was published:2023, Mental Health Gap Action Programme (‎mhGAP)‎ guideline for mental, neurological and substance use disorders, [‎3rd ed.]‎.

View latest version (2023)

Bibliographic Info

GuidelineUpdate of the Mental Health Gap Action Programme (mhGAP) guidelines for mental, neurological and substance use disorders, 2015
Year of Publication2015
Issuing InstitutionWorld Health Organization

Recommendation

Status
Retired

Recommended in favor

Conditional

In adults with established status epilepticus, i.e. seizures persisting after two doses of benzodiazepines, either intravenous valproic acid, intravenous phenobarbital or intravenous phenytoin can be used with appropriate monitoring. Intravenous valproic acid is preferred over intravenous phenobarbital or intravenous phenytoin because of its superior risk-benefit profile. The choice of these medications depends on local resource settings, including availability and facilities for monitoring. Where intravenous infusion may not be feasible, intramuscular phenobarbital remains an option, with appropriate monitoring. Phenytoin and valproic acid should not be given intramuscularly.

Powered byEpistemonikos Foundation